OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
9229$199.0059

Sunwels Co Ltd

Healthcare Facilities & ServicesVerified

Sunwels Co Ltd has a liquidity position that is characterized by a current ratio of 1.78, indicating that the company has sufficient current assets to cover its current liabilities. However, the company's free cash flow is negative at -3996000000.0 JPY, which suggests that it is spending more on capital expenditures than it is generating in operating cash flow. The company's profitability is underperforming, with a return on equity of -0.1074 and a return on assets of -0.0237, both of which are negative. This indicates that the company is not generating returns that exceed its cost of capital, and it is not effectively utilizing its assets to generate profit. Sunwels' business is primarily focused on the nursing care segment, which is its only disclosed segment. The company's geographic exposure is concentrated in Japan, as it is a Japan-based company with no other geographic regions mentioned in the provided data. The company's growth trajectory is not clearly defined, as there is no outlook data provided for the current or next fiscal year. However, the company's revenue for the latest period is 26496000000.0 JPY, and its net income is negative at -925000000.0 JPY, indicating a decline in profitability. The risk assessment for Sunwels indicates a medium level of liquidity risk, with a key flag noting that net cash is negative after subtracting total debt. The dilution risk is assessed as low, and there are no specific dilution sources mentioned in the provided data. Recent events related to Sunwels include the disclosure of its financial snapshot, which shows a net loss and a negative free cash flow. There are no specific recent filings or transcripts mentioned in the provided data that would indicate significant changes in the company's operations or financial position.

30-day price · 9229-56.00 (-22.7%)
Low$184.00High$271.00Close$191.00As of17 May, 00:00 UTC
Profile
CompanySunwels Co Ltd
Ticker9229.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Sunwels Co Ltd operates nursing care facilities in Japan, providing services for Parkinson's disease patients, cancer and intractable disease patients, long-term care recipients, and dementia patients, including communal living care, day care, and home nursing services.

Classification. Sunwels is classified in the Healthcare sector under Healthcare Services & Equipment, with a confidence level of 0.92, and is categorized under Healthcare Facilities & Services.

Sunwels Co Ltd has a liquidity position that is characterized by a current ratio of 1.78, indicating that the company has sufficient current assets to cover its current liabilities. However, the company's free cash flow is negative at -3996000000.0 JPY, which suggests that it is spending more on capital expenditures than it is generating in operating cash flow. The company's profitability is underperforming, with a return on equity of -0.1074 and a return on assets of -0.0237, both of which are negative. This indicates that the company is not generating returns that exceed its cost of capital, and it is not effectively utilizing its assets to generate profit. Sunwels' business is primarily focused on the nursing care segment, which is its only disclosed segment. The company's geographic exposure is concentrated in Japan, as it is a Japan-based company with no other geographic regions mentioned in the provided data. The company's growth trajectory is not clearly defined, as there is no outlook data provided for the current or next fiscal year. However, the company's revenue for the latest period is 26496000000.0 JPY, and its net income is negative at -925000000.0 JPY, indicating a decline in profitability. The risk assessment for Sunwels indicates a medium level of liquidity risk, with a key flag noting that net cash is negative after subtracting total debt. The dilution risk is assessed as low, and there are no specific dilution sources mentioned in the provided data. Recent events related to Sunwels include the disclosure of its financial snapshot, which shows a net loss and a negative free cash flow. There are no specific recent filings or transcripts mentioned in the provided data that would indicate significant changes in the company's operations or financial position.
Key takeaways
  • The company's liquidity position is characterized by a current ratio of 1.78, but it has a negative free cash flow of -3996000000.0 JPY.
  • Sunwels' profitability is underperforming, with a return on equity of -0.1074 and a return on assets of -0.0237, both of which are negative.
  • The company's business is primarily focused on the nursing care segment, with geographic exposure concentrated in Japan.
  • The risk assessment for Sunwels indicates a medium level of liquidity risk and a low level of dilution risk.
  • Recent events related to Sunwels include the disclosure of its financial snapshot, which shows a net loss and a negative free cash flow.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$26.50B
Gross profit$4.92B
Operating income$410.0M
Net income-$925.0M
R&D
SG&A
D&A
SBC
Operating cash flow$1.88B
CapEx-$4.21B
Free cash flow-$4.00B
Total assets$38.99B
Total liabilities$30.38B
Total equity$8.62B
Cash & equivalents$5.64B
Long-term debt$22.49B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$199.00
Market cap$6.45B
Enterprise value$23.31B
P/E
Reported non-GAAP P/E
EV/Revenue0.9
EV/Op income56.8
EV/OCF12.4
P/B0.8
P/Tangible book0.8
Tangible book$8.62B
Net cash-$16.85B
Current ratio1.8
Debt/Equity2.6
ROA-2.4%
ROE-10.7%
Cash conversion-2.0%
CapEx/Revenue-15.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric9229Activity
Op margin1.5%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin-3.5%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin18.5%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-15.9%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity261.0%71.3% medp25 60.7% · p75 71.3%top quartile
Observations
IR observations
Mean price target770.00 JPY
Median price target770.00 JPY
High price target770.00 JPY
Low price target770.00 JPY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-74.00 JPY
Last actual EPS-29.12 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:07 UTC#4bbc3698
Market quoteclose JPY 199.00 · shares 0.03B diluted
no public URL
2026-05-10 03:07 UTC#94c9dc23
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:10 UTCJob: 2d1027a7